Follow on Google News News By Tag * Lims * Core Facility Lab * Genotyping Lab Automation * Gene Sequencing Lab Automation * Biobanks * More Tags... Industry News News By Location Country(s) Industry News
Follow on Google News | Ocimum Biosolutions Announces “The Great Exchange” - LIMS Swap Program.Ocimum Biosolutions Announces “The Great Exchange” - LIMS Swap Program Program offers license exchange of existing COTS (Commercial Off-the-Shelf), home grown and custom laboratory data systems for Biotracker™ LIMS licenses
By: Ocimum Biosolutions ”Other LIMS providers have offered trade-in programs before. What makes this program so revolutionary is the inclusion of home grown and custom built data/lab management systems,” said Howard Rosenberg, Executive Director – LIMS. “We, at Ocimum, believe that an organization’ For more details on “The Great Exchange” – LIMS Swap Program please click on the following link: http://lims.ocimumbio.com/ About Biotracker™ Biotracker™ is a specialty Lab Information Management Solution for enhancing productivity and effectiveness in life sciences research laboratories. Biotracker™ addresses the challenges of supporting multi-disciplinary labs, collaboration and data management needs. Biotracker™ offers several specialty modules that address the needs in life sciences research laboratories performing Biobanking, Gene Expression, Genotyping, DNA Sequencing, and/or Proteomics. For more details, please visit www.lims.ocimumbio.com # # # About Ocimum Biosolutions Ocimum Biosolutions is a global integrated genomics services company with over 250 employees in Hyderabad, India, Gaithersburg, MD in the US and The Netherlands. Ocimum provides comprehensive genomic reference databases, life science lab information management solutions, GLP-compliant microarray services and essential research consumables. Over 2/3rd of the top 25 pharma companies, leading research institutes and emerging biotech companies worldwide have chosen us as their preferred outsourcing partner and utilize our expertise for understanding underlying mechanisms of diseases, discovery and prioritization of gene targets and biomarkers. For more information, please visit www.ocimumbio.com End
Account Email Address Disclaimer Report Abuse
|
|